Please use this identifier to cite or link to this item:
Type: Outro documento
Title: Expression modulation of different S6Ks isoforms in prostate cancer cell lines leads to alterations in proliferation, migration and chemotherapy resistance
Author: Freitas, Lidia
Pavan, Isadora
Amaral, Camila
Bajgelman, Marcio
Simabuco, Fernando
Abstract: The mTOR pathway is stimulated by high amounts of amino acids, ATP, and insulin and several studies have shown that mTOR is active in various biochemical processes involved in cell growth and metabolism. The S6Ks proteins have shown an important role in the mTOR signaling, acting as effectors of this pathway. Many works have demonstrated the participation of the mTOR pathway in cancer, but there is currently a demand to better characterize the S6Ks isoforms in this disease. The present work aimed to study the roles of p70‐S6K1, p85‐S6K1 and p54‐S6K2 isoforms in cancer, using DU145 and PC3 prostate cancer cell lines. Our results indicate that p85‐S6K1 isoform enhances proliferation and colony formation of DU145 and PC3 cells. Besides, overexpression of both S6K1 isoforms increased migration of PC3 cells in scratch assay. Moreover, all S6Ks isoforms when overexpressed increased docetaxel resistance of PC3 cells. Finally, knockdown experiments against S6K1 and S6K2 had complemented our data so far. In conclusion, we have identified different cellular effects of S6Ks isoforms in an in vitro model of prostate cancer
Subject: Neoplasias da próstata
Country: Estados Unidos
Editor: Federation of American Societies for Experimental Biology
Rights: Fechado
Date Issue: 2015
Appears in Collections:FCA - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
000361722701344.pdf219.33 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.